𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gemcitabine/Carboplatin Versus Cisplatin/Etoposide for Patients With Poor-Prognosis Small Cell Lung Cancer: A Phase III Randomized Trial With Quality-of-Life Evaluation

✍ Scribed by Jeremy P.C. Steele

Book ID
114105269
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
594 KB
Volume
28
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, randomized, Phase II stud
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma
✍ Filippo De Marinis; Fabrizio Nelli; Marco Lombardo; Francesco Ferraú; Santi Barb 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and toxicity of combined cisplatin, etoposide, and gemcitabine (PEG) and combined cisplatin plus gemcitabine (PG) in previously untreated patients with extensive‐stage and poor‐prognosis limited‐stage small‐cell lun